ENOV Stock Analysis: Buy, Sell, or Hold?
ENOV - Enovis Corporation
$22.04
-0.67 (-2.95%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When ENOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ENOV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.07
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$21.78
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ENOV is currently trading at $22.04, which is considered oversold relative to its 30-day fair value range of $23.25 to $27.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.6) compared to its historical average (7.7). Remarkably, the market is currently pricing in an annual earnings decline of 5.1% over the next few years. This pessimistic expectation contrasts with the company's recent 153.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ENOV is in a strong downtrend. Immediate support is located at $21.00, while resistance sits at $24.81.
Market Sentiment: ENOV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $45.45 (+100.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENOV is in a strong downtrend. Immediate support is located at $21.00, while resistance sits at $24.81.
Market Sentiment: ENOV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $45.45 (+100.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$23.25 -
$27.75
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding ENOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.2% below Wall St target ($45.45)
Fair Price Analysis
30-Day Fair Range
$23.25 -
$27.75
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$21.00
Resistance Level
$24.81
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
6.62
Wall Street Target
$45.45
(+100.2%)
Revenue Growth (YoY)
8.6%
Earnings Growth (YoY)
153.1%
Profit Margin
-61.2%
Valuation Discount vs History
-5.1% cheaper
PE vs Historical
6.6 vs 7.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.1%
(market-implied from PE analysis)
1-Year Target
$21.55
(-5%)
2-Year Target
$20.45
(-10%)
3-Year Target
$19.41
(-15%)
3-Yr Target (if PE normalizes)
(PE: 7→8)
$22.57
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 7.7%)
$95.49
(+321%)
Base:
(SPY PE: 6.6, Growth: 7.7%)
$28.36
(+25%)
Bear:
(PE: 5.6, Growth: 7.7%)
$24.11
(+6%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.6 to 7.7
Stabilization Target:
$26.40
(+16.3%)
PE Expansion Potential:
+16.3%
Last updated: January 31, 2026 6:10 AM ET
Data refreshes hourly during market hours. Next update: 7:10 AM
Data refreshes hourly during market hours. Next update: 7:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENOV showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Damien Mcdonald
BUY
6457 shares
2025-09-11
Bradley J Tandy
BUY
3200 shares
2025-08-22
Phillip Benjamin (Ben) B…
BUY
2500 shares
2025-08-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced ENOV Option Strategies
Professional options setups generated by AI based on today's ENOV price and gamma walls.
